The utility of cfDNA as a diagnostic tool in the management of EGFR-mutated non-small cell lung cancer (NSCLC): our regional off-study experience
Autor: | Nageshwaran, S., Ping, B., Mehta, A., Ezhil, V., Feng, G., Hall, J., Shaheed, M., Amin, N., Faulkes, C., Collins, N., Illsley, M., Matthew, H., Bagwan, I., Lee, K., Hewish, M. |
---|---|
Zdroj: | In Lung Cancer January 2019 127 Supplement 1:S15-S15 |
Databáze: | ScienceDirect |
Externí odkaz: |